|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
$1,180
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
$600
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
$1,256
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
$2,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
$2,500
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
$26,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
$2,495
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
$47,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S1
|
$56,922
|
$9,108
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S2
|
$165,708
|
$26,513
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-05
|
$2,260,718
|
$361,715
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
WHI Hormones and Gynecologic Cancers Study
|
ZIA CP010126-10538
|
$84,763
|
$42,382
|
Trabert, Britton
|
DCEG (NCI)
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-04
|
$1,316,888
|
$65,844
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-05
|
$592,247
|
$29,612
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-03S1
|
$50,000
|
$2,500
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-04
|
$700,000
|
$35,000
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-04
|
$688,299
|
$17,207
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-17S3
|
$2,156,000
|
$86,240
|
HOLCOMBE, RANDALL
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study
|
2U01CA164973-06
|
$3,176,130
|
$317,613
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-04
|
$592,771
|
$14,819
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Training of Academic Gynecologic Oncologists
|
5T32CA101642-12
|
$468,471
|
$159,280
|
LU, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-33
|
$570,788
|
$142,697
|
DAVIDSON, NANCY
|
UNIVERSITY OF WASHINGTON
|
|
The role of mRNA methylation in the progression of endometrial cancer
|
1F32CA221007-01
|
$56,694
|
$56,694
|
HARADA, BRYAN
|
UNIVERSITY OF CHICAGO
|
|
The NYU Women's Health Study
|
5UM1CA182934-03
|
$694,206
|
$138,841
|
ZELENIUCH-JAQUOTTE, ANNE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Targeted Therapy for Endometrial Cancer
|
5R01CA099908-15
|
$252,448
|
$252,448
|
LESLIE, KIMBERLY
|
UNIVERSITY OF IOWA
|
|
Systems analysis of phenotypic switch in control of cancer invasion
|
5U54CA209992-02
|
$1,937,101
|
$154,968
|
LEVCHENKO, ANDRE
|
YALE UNIVERSITY
|
|
Systematic Functional Characterization of RNA Editing in Endometrial Cancer
|
5R01CA175486-04
|
$332,000
|
$332,000
|
LIANG, HAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
SWOG Network Group Operations Center of the NCTN
|
3U10CA180888-04S1
|
$894,348
|
$8,943
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
SWOG Network Group Operations Center of the NCTN
|
5U10CA180888-04
|
$7,617,946
|
$76,179
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$24,641
|
$246
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer
|
3R01CA176502-04S1
|
$60,511
|
$60,511
|
GOLD, LESLIE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer
|
5R01CA176502-04
|
$579,879
|
$579,879
|
GOLD, LESLIE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Silent Markers in Endometrial and Ovarian Tissue
|
ZIA CP010126-10302
|
$123,481
|
$61,741
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
Signature-guided therapy for mismatch repair defective cancers
|
1R01CA218287-01
|
$373,331
|
$186,666
|
LIN, SHIAW-YIH
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Revving-Up Exercise for Sustained Weight-Loss by Altering Neurological Reward & D
|
5R01CA175100-05
|
$432,930
|
$432,930
|
NOCK, NORA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Revision: MD Anderson Gynecologic SPORE for Uterine Cancers
|
3P50CA098258-12S1
|
$192,000
|
$192,000
|
LU, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
$352,416
|
N/A
|
National Institutes of Health
|
|
Replication fork remodeling and genomic stability
|
5R01CA197774-02
|
$347,293
|
$173,647
|
CICCIA, ALBERTO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Polish Gynecologic Cancer Case-Control Study
|
ZIA CP010126-10524
|
$106,362
|
$53,181
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
PLCO - Ovarian cancer and endometrial cancers
|
ZIA CP010152-00030
|
$75,381
|
$37,690
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
Pilot Study: Collection, Analysis of Human Ovarian Surface Epithelial Cells
|
ZIA CP010144-10376
|
$29,937
|
$10,478
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
Phase I trial of intravenous vesicular stomatitis virus for treatment of metastatic endometrial cancer
|
1R01CA207240-01A1
|
$472,577
|
$472,577
|
BAKKUM-GAMEZ, JAMIE
|
MAYO CLINIC ROCHESTER
|
|
Pathobiology and Mechanism of Progesterone Resistance in Human Endometrial Cancer
|
5R01CA183877-03
|
$352,275
|
$352,275
|
MEMARZADEH, SANAZ
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
OSU as Network Lead Academic Participating Site for the NCI NCTN
|
5U10CA180850-04
|
$1,307,073
|
$32,677
|
VERSCHRAEGEN, CLAIRE
|
OHIO STATE UNIVERSITY
|
|
Nutrition and Physical Activity Assessment Study (NPAAS)
|
5R01CA119171-10
|
$799,090
|
$199,773
|
NEUHOUSER, MARIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER
|
3U10CA180868-04S1
|
$133,213
|
$1,665
|
WOLMARK, NORMAN
|
NRG ONCOLOGY FOUNDATION, INC.
|
|
NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER
|
5U10CA180868-04
|
$13,475,638
|
$168,445
|
WOLMARK, NORMAN
|
NRG ONCOLOGY FOUNDATION, INC.
|
|
Novel tumorigenic mechanisms of the LKB1 tumor suppressor
|
5R01CA196912-02
|
$370,575
|
$370,575
|
CASTRILLON, DIEGO
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Novel Tumor Suppressing Kinases in Cancer
|
ZIA BC 011690
|
$338,426
|
$135,370
|
Brognard, John
|
CCR (NCI)
|
|
Novel epigenetic paradigm in endometrial cancer recurrence
|
5R01CA172279-04
|
$308,364
|
$308,364
|
HUANG, TIM
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
Total relevant funding to Uterine for this search: $17,505,925
|